Edit
Soundbite Medical Solutions Inc.
https://soundbitemedical.com/Last activity: 30.11.2021
Active
SoundBite is a medical devices start-up, Montreal and Sherbrooke-based, developing and commercializing proprietary shockwave device and generator technology delivered within the cardiovascular system to treat chronic total occlusions (CTO’s).
The company will target CTO’s in patients with peripheral artery disease (PAD) and coronary artery disease (CAD), disease states that affect over 12 million and 8 million Americans, respectively.
The company will target CTO’s in patients with peripheral artery disease (PAD) and coronary artery disease (CAD), disease states that affect over 12 million and 8 million Americans, respectively.
Location: Canada, Montreal (06), Montreal
Employees: 11-50
Founded date: 2013
Investors 5
| Date | Name | Website |
| - | adMare Bio... | admarebio.... |
| 31.05.2021 | Aligo Inno... | technology... |
| - | Groupe Ros... | grouperosk... |
| - | Anges Québ... | angesquebe... |
| - | FundRx | fundrx.com |
Mentions in press and media 6
| Date | Title | Description |
| 30.11.2021 | Soundbite Medical Announces Issuance Of A Fifth U.S. Patent Covering Novel Active Balloon Devices Intended For Plaque Modification Of Calcified Arteries | Soundbite Medical Solutions Inc. (SBMS), a medical device company dedicated to developing solutions for the interventional treatment of calcific occlusive peripheral and coronary arterial diseases, today announced that the United States Pat... |
| 27.07.2021 | Soundbite Medical Solutions Announces Issuance of a Fourth U.S. Patent Further Expanding Coverage of its Core Technology | Soundbite Medical Solutions Inc. (SBMS), a medical device company dedicated to developing solutions for the interventional treatment of calcific peripheral and coronary arterial diseases, today announced that the United States Patent and Tr... |
| 18.05.2021 | Soundbite Medical Solutions Announces Issuance of a Third U.S. Patent Expanding Coverage of its Core Technology | Soundbite Medical Solutions Inc. (SBMS), a medical device company dedicated to developing solutions for the interventional treatment of calcific peripheral and coronary arterial diseases, today announced that the United States Patent and Tr... |
| 22.04.2021 | Soundbite Medical Solutions : Announces FDA Approval for SoundBite® Crossing System - Peripheral (14P) | Soundbite announces FDA 510(k) Approval for SoundBite® Crossing System - Peripheral (SCS-P) with the 0.014” Active Wire (14P). The SoundBite® Crossing System – Peripheral (14P) is a recanalization tool, designed to help physician’s placemen... |
| 10.02.2021 | Soundbite Medical Solutions Announces Health Canada Approval for SoundBite® Crossing System ‐ Peripheral (14P) | Soundbite announces Health Canada Approval for SoundBite Crossing System ‐ Peripheral (SCS-P) with the 0.014” Active Wire (14P). The SCS-P (14P) is intended for the treatment of patients suffering from peripheral artery disease (PAD) with h... |
| 21.01.2020 | adMare Portfolio Company Receives FDA 510(k) Clearance | adMare BioInnovations Portfolio Company SoundBite Receives FDA 510(k) Clearance of the SoundBite™ Crossing System – Peripheral MONTREAL – SoundBite Medical Solutions Inc. (SBMS)today announces it has received U.S. Food and Drug Administrati... |